SCHEMBL3926487

SCHEMBL3926487

Cc1csc(S(=O)(=O)C2CC2c2cc(N3CCOCC3)nc(-c3ccc(N)cc3)n2)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.42
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
MTOR P42345 5/20 0.41
PIK3CA P42336 7/20 0.40
CYP2C9 P11712 3/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2C19 P33261 2/20 0.40
ALDH1A1 P00352 1/20 0.40
PIK3R1 P27986 1/20 0.40
ATR Q13535 4/20 0.39
MAPT P10636 2/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
HSD17B10 Q99714 1/20 0.39
HTT P42858 1/20 0.38
PIK3CD O00329 2/20 0.37
PIK3CB P42338 1/20 0.37
PIK3CG P48736 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3934294 0.84 PIK3CA (0.58) MTORPIK3CAPIK3CDPIK3CG
SCHEMBL3928191 0.83 KMT2A (0.36) MEN1KMT2APIK3CACYP1A2ALDH1A1
SCHEMBL3923596 0.83 PIK3CA (0.50) MTORPIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL3935222 0.80 PIK3CA (0.47) MTORPIK3CAPIK3CDPIK3CG
SCHEMBL4200332 0.77 ATR (0.57) SMN1; SMN2MEN1KMT2AMTORPIK3CA
SCHEMBL3929252 0.74 PIK3CA (0.62) MTORPIK3CAPIK3CD
SCHEMBL3929141 0.74 PIK3CA (0.49) MTORPIK3CAPIK3CD
SCHEMBL3926037 0.74 PIK3CA (0.51) MTORPIK3CAPIK3CD
SCHEMBL3927786 0.73 PIK3CA (0.48) MTORPIK3CAPIK3CD
SCHEMBL3935715 0.73 MTOR (0.63) MTORPIK3CAPIK3CDPIK3CBPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2074118-A2 TRISUBSTITUTED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES AstraZeneca AB (SE) 2009-07-01 EP disclosed
WO-2009007748-A2 TRISUBSTITUTED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES ASTRAZENECA AB (SE) 2009-01-15 WO disclosed